These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 23068271

  • 41. Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies.
    Parissi-Crivelli A, Parissi-Crivelli JM, Girón JA.
    J Clin Microbiol; 2000 Jul; 38(7):2696-700. PubMed ID: 10878066
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The kinetics of antibody production to antigens of Escherichia coli O157 in a pregnant woman with haemolytic uraemic syndrome.
    Chart H, Perry NT, Cheasty T, Wright PA.
    J Med Microbiol; 2002 Jun; 51(6):522-525. PubMed ID: 12018661
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.
    Paton AW, Srimanote P, Woodrow MC, Paton JC.
    Infect Immun; 2001 Nov; 69(11):6999-7009. PubMed ID: 11598075
    [Abstract] [Full Text] [Related]

  • 46. Complement in typical hemolytic uremic syndrome.
    Orth D, Würzner R.
    Semin Thromb Hemost; 2010 Sep; 36(6):620-4. PubMed ID: 20865638
    [Abstract] [Full Text] [Related]

  • 47. Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin.
    Gansheroff LJ, Wachtel MR, O'Brien AD.
    Infect Immun; 1999 Dec; 67(12):6409-17. PubMed ID: 10569757
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Human milk secretory antibodies against attaching and effacing Escherichia coli antigens.
    Noguera-Obenza M, Ochoa TJ, Gomez HF, Guerrero ML, Herrera-Insua I, Morrow AL, Ruiz-Palacios G, Pickering LK, Guzman CA, Cleary TG.
    Emerg Infect Dis; 2003 May; 9(5):545-51. PubMed ID: 12737737
    [Abstract] [Full Text] [Related]

  • 51. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI.
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [Abstract] [Full Text] [Related]

  • 52. Human colostrum and serum contain antibodies reactive to the intimin-binding region of the enteropathogenic Escherichia coli translocated intimin receptor.
    Sanches MI, Keller R, Hartland EL, Figueiredo DM, Batchelor M, Martinez MB, Dougan G, Careiro-Sampaio MM, Frankel G, Trabulsi LR.
    J Pediatr Gastroenterol Nutr; 2000 Jan; 30(1):73-7. PubMed ID: 10630443
    [Abstract] [Full Text] [Related]

  • 53. [Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].
    Allerberger F, Sölder B, Caprioli A, Karch H.
    Wien Klin Wochenschr; 1997 Sep 19; 109(17):669-77. PubMed ID: 9381722
    [Abstract] [Full Text] [Related]

  • 54. Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model.
    Calderon Toledo C, Arvidsson I, Karpman D.
    Infect Immun; 2011 Jun 19; 79(6):2224-33. PubMed ID: 21402761
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Use of virulence factor-specific egg yolk-derived immunoglobulins as a promising alternative to antibiotics for prevention of attaching and effacing Escherichia coli infections.
    Girard F, Batisson I, Martinez G, Breton C, Harel J, Fairbrother JM.
    FEMS Immunol Med Microbiol; 2006 Apr 19; 46(3):340-50. PubMed ID: 16553806
    [Abstract] [Full Text] [Related]

  • 58. Human colostrum contains IgA antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: intimin, BfpA, EspA, and EspB.
    Loureiro I, Frankel G, Adu-Bobie J, Dougan G, Trabulsi LR, Carneiro-Sampaio MM.
    J Pediatr Gastroenterol Nutr; 1998 Aug 19; 27(2):166-71. PubMed ID: 9702647
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.